Literature DB >> 17499508

Relationship between malignant subtypes of meningioma and clinical outcome.

Kwang-Won Ko1, Do-Hyun Nam, Doo-Sik Kong, Jung-Ii Lee, Kwan Park, Jong-Hyun Kim.   

Abstract

We evaluated the relationship between histological malignant subtypes (WHO grade II or III) of meningioma and clinical outcome. Of 485 patients treated surgically for intracranial meningioma at our hospital between 1994 and 2004, 49 (10%; 18 male, 31 female) had potentially malignant features. The histological tumor subtypes within this group of patients included: atypical (n=23); clear cell (n=3); chordoid (n=5); rhabdoid (n=16); and anaplastic (n=4). Correlations among prognosis, recurrence, and the following factors were analyzed for each histological subtype: the Simpson grade of surgical resection (grades I-III vs. grade IV), tumor location (convexity vs. other), the Ki-67 index, and use of postoperative radiotherapy. The median value of the Ki-67 index was 16.2% (range: 1.0-57.2%). The surgical resections were of Simpson grades I-III and IV in 43 and six of the 49 patients, respectively. Tumors recurred after the initial surgical resection in 14 of the 49 patients. In view of the relatively high proportion of malignant subtypes (10%), we suggest that all meningiomas should be evaluated for malignancy. The extent of surgical resection, the histological subtype, and the Ki-67 index can help to predict the clinical outcome for meningioma patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499508     DOI: 10.1016/j.jocn.2006.05.005

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  17 in total

1.  WHO grade II and III meningiomas: a study of prognostic factors.

Authors:  Anne Durand; François Labrousse; Anne Jouvet; Luc Bauchet; Michel Kalamaridès; Philippe Menei; Robert Deruty; Jean Jacques Moreau; Michelle Fèvre-Montange; Jacques Guyotat
Journal:  J Neurooncol       Date:  2009-06-27       Impact factor: 4.130

Review 2.  Variants of meningiomas: a review of imaging findings and clinical features.

Authors:  Akira Kunimatsu; Natsuko Kunimatsu; Kouhei Kamiya; Masaki Katsura; Harushi Mori; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2016-05-02       Impact factor: 2.374

3.  Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Authors:  William L Hwang; Ariel E Marciscano; Andrzej Niemierko; Daniel W Kim; Anat O Stemmer-Rachamimov; William T Curry; Fred G Barker; Robert L Martuza; Jay S Loeffler; Kevin S Oh; Helen A Shih; Mykol Larvie
Journal:  Neuro Oncol       Date:  2015-11-22       Impact factor: 12.300

4.  Chordoid meningioma: a report of ten cases.

Authors:  Martha Lilia Tena-Suck; Miguel Angel Collado-Ortìz; Citlaltepetl Salinas-Lara; Rabindhranath García-López; Noemi Gelista; Daniel Rembao-Bojorquez
Journal:  J Neurooncol       Date:  2010-01-22       Impact factor: 4.130

5.  18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.

Authors:  Jeong Won Lee; Keon Wook Kang; Sung-Hye Park; Sang Mi Lee; Jin Chul Paeng; June-Key Chung; Myung Chul Lee; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-18       Impact factor: 9.236

6.  Childhood and juvenile meningiomas.

Authors:  Xing Gao; Rong Zhang; Ying Mao; Yin Wang
Journal:  Childs Nerv Syst       Date:  2009-07-30       Impact factor: 1.475

7.  Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.

Authors:  Mirco Bartolomei; Lisa Bodei; Concetta De Cicco; Chiara Maria Grana; Marta Cremonesi; Edoardo Botteri; Silvia Melania Baio; Demetrio Aricò; Maddalena Sansovini; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-25       Impact factor: 9.236

8.  uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.

Authors:  Odysseas Kargiotis; Chandramu Chetty; Venkateswara Gogineni; Christopher S Gondi; Sai Muralikrishna Pulukuri; Athanassios P Kyritsis; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

Review 9.  Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.

Authors:  Rachael A Vaubel; Selby G Chen; David R Raleigh; Michael J Link; Michael R Chicoine; Igor Barani; Sarah M Jenkins; Patrice Abell Aleff; Fausto J Rodriguez; Peter C Burger; Sonika Dahiya; Arie Perry; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2015-12-07       Impact factor: 3.685

10.  Papillary meningioma: clinical and histopathological observations.

Authors:  Dai-Jun Wang; Ming-Zhe Zheng; Ye Gong; Qing Xie; Yin Wang; Hai-Xia Cheng; Ying Mao; Ping Zhong; Xiao-Ming Che; Cheng-Chuan Jiang; Feng-Ping Huang; Kang Zheng; Shi-Qi Li; Yu-Xiang Gu; Wei-Min Bao; Bo-Jie Yang; Jing-Song Wu; Li-Qian Xie; Hai-Liang Tang; Hong-Da Zhu; Xian-Cheng Chen; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.